Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (71-80 of 426) with videos related to

Pageof 43
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 8, 2002
Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detectionVittoria Rizzo, Camillo Porta, Mauro Moroni, et al.
Expert Review of Anticancer Therapy|November 26, 2011
Optimizing treatment for metastatic renal cell carcinomaJean-Jacques Patard, Camillo Porta, John Wagstaff, et al.
Recenti Progressi in Medicina|August 1, 2015
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma]Palma Giglione, Fiorella Lombardo, Ilaria Toscani, et al.
Journal of Nephrology|November 26, 2020
The basics of onco-nephrology in the renal clinicLaura Cosmai, Camillo Porta, Marina Foramitti, et al.
The Lancet. Oncology|June 2, 2022
Abemaciclib for malignant pleural mesotheliomaValerio Nardone, Camillo Porta, Rocco Giannicola, et al.
Frontiers in Pharmacology|July 7, 2017
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right PatientCamillo Porta, Alessandra Ferrari, Anna M Czarnecka, et al.
Expert Opinion on Pharmacotherapy|January 20, 2017
Pharmacotherapy for treating metastatic clear cell renal cell carcinomaCamillo Porta, Silvia Chiellino, Alessandra Ferrari, et al.
Journal of Nephrology|October 15, 2024
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrologyMarta Pirovano, Carlo Ganini, Maurizio Gallieni, et al.
BMC Cancer|July 14, 2016
Insulin-like growth factor-1 signaling in renal cell carcinomaAdam F Tracz, Cezary Szczylik, Camillo Porta, et al.
Journal of Cancer|July 1, 2011
Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?Camillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Pageof 43

Showing results (71-80 of 426) with videos related to

Sort By:
Pageof 43
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 8, 2002
Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detectionVittoria Rizzo, Camillo Porta, Mauro Moroni, et al.
Expert Review of Anticancer Therapy|November 26, 2011
Optimizing treatment for metastatic renal cell carcinomaJean-Jacques Patard, Camillo Porta, John Wagstaff, et al.
Recenti Progressi in Medicina|August 1, 2015
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma]Palma Giglione, Fiorella Lombardo, Ilaria Toscani, et al.
Journal of Nephrology|November 26, 2020
The basics of onco-nephrology in the renal clinicLaura Cosmai, Camillo Porta, Marina Foramitti, et al.
The Lancet. Oncology|June 2, 2022
Abemaciclib for malignant pleural mesotheliomaValerio Nardone, Camillo Porta, Rocco Giannicola, et al.
Frontiers in Pharmacology|July 7, 2017
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right PatientCamillo Porta, Alessandra Ferrari, Anna M Czarnecka, et al.
Expert Opinion on Pharmacotherapy|January 20, 2017
Pharmacotherapy for treating metastatic clear cell renal cell carcinomaCamillo Porta, Silvia Chiellino, Alessandra Ferrari, et al.
Journal of Nephrology|October 15, 2024
Management of cytotoxic chemotherapy in patients undergoing dialysis: a still unresolved issue of onconephrologyMarta Pirovano, Carlo Ganini, Maurizio Gallieni, et al.
BMC Cancer|July 14, 2016
Insulin-like growth factor-1 signaling in renal cell carcinomaAdam F Tracz, Cezary Szczylik, Camillo Porta, et al.
Journal of Cancer|July 1, 2011
Immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?Camillo Porta, Chiara Paglino, Ilaria Imarisio, et al.
Pageof 43